Nexia Health Technologies Inc (NGH.H) Quote

Missed that comment-- Oh well! Now We wait for the "pinks"-- going to look for my peanuts- Good night!

Focus on the horrible PPS, focus on the horrible volume, focus on the zippo substantive accomplishments by the "management team", focus on how many times others have been right and the pushers have been wrong, focus on how many times the pushers have been humiliated because of their hilariously wron

Count down?? 4

https://m.youtube.com/watch?v=y_gp8rU8SPY

GLTA

Guy took his wife to the ER (nothing serious, she needed an IV)

https://x.com/LibertyCappy/status/1839013289218712049

Or, perhaps Big Pharma, with its deep pockets, will be more willing than the CCCs to give some kind of monetary settlement to ENZC shareholders (and hopefully to ENZC SAFE-holders like myself) just to make the shareholders and SAFE-holders go away.

Warrants are like options. One pays to have the option to purchase shares at a fixed price within a specified period. In this case FORW paid SRNW $400,000 cash to SRNW in exchange for the two warrants. I'm guessing the $400,000 came from the $2m GS received from HMBL's warrant settlement.

This should go up really nice with the next phase results

Yeah, I had added/averaged down when it dropped below $110, had 400 shares total.
Sold them before the news hit about more shares being priced.
For me this one is a little too risky in the current market conditions for me to keep a position.

It would also be preferred if the shorts limited their posts to one sentence.

You cannot short a subpenny stock.

Nah, you missed it!! That's his true colors coming through!! Remember when I made that morality comment saying did he feel for my ancestors he blew his top!!

https://www.cbssports.com/mlb/news/braves-pushed-back-on-rescheduling-games-vs-mets-as-hurricane-helene-threatened-schedule-per-report/

If you had a date certain for EDEN approval you could probably estimate when the BLA would be submitted, but that isn't possible. As for the FDA's involvement, all the regulators involved in the trial remain involved with the vaccine. The UK has the facility where sufficient manual production is a

The Phase 2 schizophrenia trial using Anavex 3-71, which is a muscarinic M1 PAM (positive allosteric modulator) and a sigma-1 receptor agonist, is ahead of schedule. Expect that part A of the trial has been successfully completed and part B of the trial has started recruiting and treating participan

Expect HUGE NEWS TOMORROW concerning AVXL.

Good luck and GOD bless,

It was already known

old.bitchute.com/video/Ijml7rEZMG92/ By some

Ver, yeppers Whales hungry looks like RH in rhe know so Follow Da Whales. Rocking and layn low here. Watchn trip wires and such. Wait till WHALE FOMO happens and it'll be a EPIC scene in my book. SHIBA STRONG AND ARMY HODL LONG!!!

Yeah, he is an ex police chief and he had some baggage coming in. He ran his campaign on a "restore law and order" type of platform with bringing back heavy handed policing as his main goal. He made a lot of voters regret their decisions after just a couple months because he made some a

Not a great little video: got MOA of AChEI wrong and generally added no value. Seems like a nice lady though.

Btw, I dont condone the thoughts or practices of the fore mentioned authors instead reject greatly their agendas and turn to Yahusha

It is not from Seeking Alpha. It is from page 12 Public Center Prise.

https://publicenterprise.org/wp-content/uploads/Smoothing-the-Housing-Investment-Cycle-Part-1.pdf

Is this from the seeking alpha article?

Hey atleast I'm not showcasing underage girls in a lewd pixxs, u showing to the world,hope your hr job don't catch this,u might be selling your scam stock here to eat, fire perv broh...

Yup

no idea-- must be associated with some type of complex! The post was me eating peanuts!!! GEEZE

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

The trial is expected to commence in 2025 and is projected to last approximately two to three years

https://ir.anixa.com/press-releases/detail/1051/anixa-biosciences-unveils-phase-2-study-plan-for-br